Debut Launches AI Designed Ingredient for Hyperpigmentation

Sep 16, 2026
Debut launched DermCeutical PNar, a biotech skin care ingredient designed to reduce hyperpigmentation and brighten skin.

Debut launched DermCeutical PNar™, a biotech skin care ingredient intended to reduce hyperpigmentation and brighten skin, the company said in a press release. Debut developed the ingredient using its AI, skin genomics, and biotechnology platform.

PNar targets biological causes of hyperpigmentation and blocks enzymes including tyrosinase to reduce melanin production. It is designed for use at a concentration of 0.45%, compared with the European Union maximum of 1% for kojic acid in face and hand products.

In a 12 week clinical study, 97% of users showed improvement in hyperpigmentation and 88% showed improvement in skin brightening. The ingredient is designed for all skin tones and is available to brand partners through Debut's United States formulation business.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.